Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Educating immune system may ease future use of stem cells

20.07.2004


Results of laboratory experiments by Johns Hopkins scientists suggest it may be possible to "educate" the immune system to recognize rather than destroy human embryonic stem cells. Doing so could reduce the risk of rejection if the primitive cells are someday transplanted into people with conditions like Parkinson’s disease, diabetes or spinal cord injuries, the researchers say.

In their experiments, described in the July 10 issue of The Lancet, the Hopkins team successfully coaxed human embryonic stem cells to become the special "flag-waving" cells that tell the immune system what is "friend" and what is "foe." In additional experiments in the lab, the researchers found that these so-called antigen presenting cells can control the responses of other immune cells, called T cells, whose job is either to attack or to co-exist with "foreign" cells.

"This is the first evidence that human embryonic stem cells can generate antigen presenting cells that could be used to educate a patient’s immune system," says Linzhao Cheng, Ph.D., assistant professor in Johns Hopkins’ Institute for Cell Engineering. "It’s a small but important step toward future clinical use of the stem cells, but many challenges remain."



Because all human cells carry proteins that identify them as coming from a particular person, even embryonic stem cells could be rejected if their identifying proteins, or antigens, don’t exactly match the recipients’.

But matching embryonic stem cells to potential recipients carries ethical dilemmas for many, since it might require destruction of more in vitro fertilized embryos to get new embryonic stem cell lines or attempting so-called therapeutic cloning (somatic cell nuclear transfer), which would use an individual’s regular cells to create the early embryos from which stem cells are derived. Cheng adds that the science is far from making the latter a practical option, and notes that neither approach provides an exact match for patients.

Even the use of powerful immune-suppressing drugs, such as those used for organ and tissue transplant recipients, would require better "matches" than today’s limited selection of embryonic stem cells can provide, says Cheng.

A paper by Hopkins researchers and others last fall suggests that to provide embryonic stem cells that acceptably and equitably match an equal percentage of various ethnic groups, at least 85 carefully selected stem cell lines would need to be established. There are currently just a few dozen validated lines of human embryonic stem cells, most scientists think.

Because of the stem cells’ flexibility, however, some scientists are trying to make the cells "stealthy" so they might escape detection by the immune system, even if they don’t perfectly match the patient. One potential stealth-inducing technique is to modify or replace the genes in the embryonic stem cell that control production of rejection-inducing proteins, but progress has been slow, Cheng says.

His team is also pursuing a second option — using the embryonic stem cells to get special immune cells. Because both the immune cells and the therapeutic cells — say pancreatic islet cells for a type I diabetic, or dopamine-producing neurons for a person with Parkinson’s disease — would be derived from the same embryonic stem cell line, they would match one another. And the immune cells then could tell the patient’s immune system that the transplanted therapeutic cells "belong."

"In some clinical situations, studies have demonstrated that if you can get immune cells to recognize the transplanted tissue as ’friend,’ then the chances of rejection are lower," says Cheng.

For example, transplanting bone marrow from an organ donor into the recipient, at the same time as or prior to transplantation of the needed organ — say, a kidney — has been associated with reduced rejection, says Cheng. The transplanted bone marrow cells co-exist with the patient’s own tissue and essentially create a new corner of the patient’s immune system that recognizes the transplanted organ as self.

"We’re presenting the first, very early suggestion that the same idea might be applicable to future applications of embryonic stem cells," says Cheng. "There still are many challenges ahead to know whether this will apply to potential uses of embryonic stem cells, but it’s important to try to address the issues of ’matching’ and rejection before the cells reach the clinic."

By bathing the human embryonic stem cells in a soup of certain proteins known to encourage the cells’ progression into various types of blood cells, postdoctoral fellows Xiangcan Zhan and Gautam Dravid and their colleagues coaxed the primitive cells to become antigen presenting cells, sentries that tell other immune cells whether to destroy or spare cells they meet. In additional experiments, the researchers also showed that these antigen presenting cells worked as they should, at least in the lab.

"The idea is that you would create a large number of the antigen presenting cells and related immune cells and give those to the patient before they get another cell type from the same embryonic stem cell line," says Cheng. "Then, the patient’s immune system would include cells that recognize the transplanted cells, preventing their destruction."

Animal experiments to prove that these human antigen presenting cells can really induce immune tolerance will be very difficult to do, he says, since any human cell would be attacked by a mouse’s immune system. Cheng says that his lab will continue looking for evidence of specific immunity and of immune tolerance induced in laboratory dishes of human embryonic stem cells.

Joanna Downer | EurekAlert!
Further information:
http://www.jhmi.edu
http://www.hopkinsmedicine.org/ice

More articles from Life Sciences:

nachricht Transport of molecular motors into cilia
28.03.2017 | Aarhus University

nachricht Asian dust providing key nutrients for California's giant sequoias
28.03.2017 | University of California - Riverside

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Transport of molecular motors into cilia

28.03.2017 | Life Sciences

A novel hybrid UAV that may change the way people operate drones

28.03.2017 | Information Technology

NASA spacecraft investigate clues in radiation belts

28.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>